Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients

Status Completed

Clinical Trial Summary

This is an observational study examining serum markers in patients who are undergoing either a cadaveric liver transplant or a living related liver transplant.

Clinical Trial Description

The Departments of Anesthesiology are conducting an observational trial of markers in the serum of patients who are undergoing liver transplantation surgery. This study will utilize the biological markers, trimethylamine-N-oxide (TMAO), NGAL, and cystatin-C, sensitive markers of renal medullary injury in the blood and allantoin, a marker of oxidative stress as indicators of renal injury in a kidney during liver transplants. It is hypothesized that: (1) these markers are less pronounced in living donor liver transplant recipient patients than in cadaveric liver transplant recipients, and (2) these markers are less pronounced in cadaveric liver transplant recipients in which a "piggy-back" technique was used versus recipients in which a total venous occlusion technique was used. This study will be done in a multi-center format, along with researchers at UCSF ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00698399
Study type	Observational
Source	Vanderbilt University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	March 2008
Completion date	February 2, 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02798861` - Controlled Attenuation Parameter (CAP) in Liver Allografts
Completed	`NCT03527238` - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine	Phase 2
Completed	`NCT01696331` - Text Messaging for Adherence in Adolescent Liver Transplant Recipients	N/A
Recruiting	`NCT05051605` - Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Recruiting	`NCT05940857` - Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry
Completed	`NCT01598987` - Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.	Phase 3
Active, not recruiting	`NCT05074160` - OCS Liver Perfusion (OLP) Post-Approval Registry
Completed	`NCT05087550` - Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation
Recruiting	`NCT04836923` - LIFT Intervention in Liver Transplant Candidates	N/A
Not yet recruiting	`NCT03666689` - Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation
Not yet recruiting	`NCT06088758` - Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool	N/A
Terminated	`NCT01230502` - Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation	N/A
Completed	`NCT00171509` - Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients	Phase 4
Not yet recruiting	`NCT06254248` - Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma	Phase 2
Recruiting	`NCT06075745` - Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates	Phase 2
Not yet recruiting	`NCT06280950` - Expanding Liver Transplant Immunosuppression Minimization Via Everolimus	Phase 2
Completed	`NCT02057484` - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Active, not recruiting	`NCT03577431` - Liver Transplantation With Tregs at MGH	Phase 1/Phase 2
Recruiting	`NCT06342557` - Transitional ePRO Diary Liver
Not yet recruiting	`NCT04265157` - Hepato-duodenal Ligament Occlusion and Classic Technique in Liver Transplant